Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LPTX | Common Stock | Options Exercise | +7.5K | +11.34% | 73.6K | Jan 26, 2024 | Direct | F1, F2 | ||
holding | LPTX | Common Stock | 414K | Jan 26, 2024 | By HealthCare Ventures IX, L.P. | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LPTX | Restricted Stock Units | Options Exercise | $0 | -7.5K | -100% | $0.00* | 0 | Jan 26, 2024 | Common Stock | 7.5K | Direct | F1, F4 |
Id | Content |
---|---|
F1 | Restricted Stock Units convert into common stock on a one-for-one basis. |
F2 | The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023. |
F3 | The reporting person is a Managing Director of HealthCare Partners IX, LLC which is the General Partner of HealthCare Partners IX, L.P., which is the General Partner of HealthCare Ventures IX, L.P. The reporting person beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein. |
F4 | On January 26, 2021, the reporting person was granted 7,500 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. |